The role of clinical equipoise and practical considerations in deciding whether to continue to provide a drug on an open-label extension study for an "unapproved indication"

Am J Bioeth. 2014;14(4):59-60. doi: 10.1080/15265161.2014.889959.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antihypertensive Agents / administration & dosage*
  • Antihypertensive Agents / economics*
  • Drug Prescriptions / standards*
  • Humans
  • Hypertension, Pulmonary / drug therapy*
  • Off-Label Use / ethics*
  • Randomized Controlled Trials as Topic / ethics*

Substances

  • Antihypertensive Agents